Another possible reason is that the in vitro experimental environment in this study differs from the in vivo tumor microenvironment where pancreatic cancer cells reside, leading to inadequate responses of CCL21 to microenvironmental cues. This evidence concerns the gene CCL21 and familial pancreatic carcinoma.